Bioactive Compound Details
| Compound ID: | B441029 |
| Source ID: | CHEMBL270995 |
| Source Type: | Small molecule |
| Compound Name: | BRIVANIB ALANINATE |
| Synonyms: | Alaninate de brivanib|Alaninato de brivanib|BMS-582664|BMS-582664-02|Brivanib alaninate|Brivanib alaninate|Brivanib alaninate|Brivanib l-alanine ester|Brivanib alaninate |
| Molecular Formula: | C22H24FN5O4 |
| SMILES: | Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1 |
| Molecular Species: | NEUTRAL |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name | |
|---|---|---|---|---|---|---|---|
| T09 | Serine/threonine-protein kinase AKT2 | AKT2 | INHIBITOR | Target is a single protein chain | P31751 | AKT2_HUMAN | Details |
| T09 | Serine/threonine-protein kinase AKT2 | AKT2 | INHIBITOR | Target is a single protein chain | P31751 | AKT2_HUMAN | Details |
| T30 | TP53-regulating kinase | TP53RK | Target is a single protein chain | Q96S44 | TP53RK_HUMAN | Details | |
| T01 | Insulin receptor | INSR | AGONIST; INHIBITOR | Target is a single protein chain | P06213 | INSR_HUMAN | Details |